Kishnani, P. S. Et Al. 2021. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients. MOLECULAR GENETICS AND METABOLISM , vol.132, no.2 .

Kishnani, P. S., Attarian, S., Borges, J. L., Bouhourd, F., Chien, Y., Choi, Y., ... Clemens, P.(2021). Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients. MOLECULAR GENETICS AND METABOLISM , vol.132, no.2.

Kishnani, Priya Et Al. "Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients," MOLECULAR GENETICS AND METABOLISM , vol.132, no.2, 2021

Kishnani, Priya S. Et Al. "Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients." MOLECULAR GENETICS AND METABOLISM , vol.132, no.2, 2021

Kishnani, P. S. Et Al. (2021) . "Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients." MOLECULAR GENETICS AND METABOLISM , vol.132, no.2.

@article{article, author={Priya S. Kishnani Et Al. }, title={Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients}, journal={MOLECULAR GENETICS AND METABOLISM}, year=2021}